Tier 3 · Filer Universe
Yarrow Bioscience, Inc.
YARW · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$30.21
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001566044
Liquidity rank
#4068
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $570,000.00 | 2025-12-31 | 0001104659-26-069925 |
| Annual diluted EPS | -0.62 | 2025-12-31 | 0001104659-26-069925 |
| Quarterly revenue | $97,000.00 | 2026-06-30 | 0001566044-26-000010 |
| Quarterly diluted EPS | -3.51 | 2026-06-30 | 0001566044-26-000010 |
SEC EDGAR Frames batch generated 2026-09-08T00:39:23.566Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerMRK · Tier 1 peerPFE · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames